Public health, personal health and pills : drug entanglements and pharmaceuticalised governance
著者
書誌事項
Public health, personal health and pills : drug entanglements and pharmaceuticalised governance
(Routledge studies in the sociology of health and illness)
Routledge, 2019
- : hbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Public Health, Personal Health and Pills explores the processes and effects of the increasing governance of our lives through pharmaceuticals, looking at the moral, interactional, social and political forces that shape our use of them. It demonstrates the ways in which social relationships and identities are developed, sustained and transformed through medication use.
Building on the extensive medicalisation of health literature, and the more recent concept of pharmaceuticalisation, this pioneering book is firmly based on empirical research and sociological theory. It brings together macro considerations of trends in pharmaceutical consumption, regulation and policy, micro considerations of the decision-making and the negotiation of medication use in homes and clinics, and an institutional analysis of the role of drug monitoring agencies, drug subsidising agencies, drug trial methodologies and the media.
This book is a contribution to a burgeoning sociological interest in medication use, and will be of interest to a multidisciplinary audience of scholars and students of sociology, science and technology studies, pharmacy and health studies.
目次
Chapter 1. Orienting to pharmaceuticalised governance
Chapter 2. The Development pharmaceutical hegemony
Chapter 3. Expanding Medicine
Chapter 4. Moral forces and medicine
Chapter 5. Medication practices in the home
Chapter 6. Sources of practices and their contestation
Chapter 7. Populations and medications
Chapter 8. Adverse reactions and the proliferation of risk
Chapter 9. Underreporting of side effects
Chapter 10. Pharmacovigilance lessons
Chapter 11. Different faces of governance
Chapter 12. Resisting pharmaceuticalised governance
Chapter 13. Drug entanglements and governance
「Nielsen BookData」 より